Shu-Zhen Chen (Xinran Qiao)

Publication Activity (10 Years)

Years Active: 2018-2019
Publications (10 Years): 2

Top Topics

Editorial Comment

Endoplasmic Reticulum Stress

Protein Protein

Top Venues

Cancer communications (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Shu-Zhen Chen, Maoluo Gan, Chen Wang, Bin Liu, Yue Shang, Yi Li, Shuzhen Chen
Tetracenomycin X Exerts Antitumour Activity in Lung Cancer Cells through the Downregulation of Cyclin D1. Marine drugs 17 (1) (2019)
Xinran Qiao, Xiaofei Wang, Yue Shang, Yi Li, Shu-Zhen Chen
Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo. Cancer communications (London, England) 38 (1) (2018)